Tartu, Estonia · Founded 2022 · Privately Held (backing)
Operator of a biotechnology company intended to develop cancer immunotherapies. Vectiopep is based in Tartu, Estonia and was founded in 2022. Its last reported valuation was $3 million in Apr 2024. It has raised $460,000.
Last reported valuation
$3.0M
Oct 2026
Priced at
—
Total raised
$460K
Last round
—
Cap table — not yet on record
Vectiopep's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Vectiopep with a free account
·Watch Vectiopep: the Monday email on marks, rounds and moves
